Analysis of PAC1 receptor gene variants in Caucasian and African American infants dying of sudden infant death syndrome

Acta Paediatrica, International Journal of Paediatrics

Volumn 102, Issue 12, 2013, Pages

  Barrett, Karlene T ^a   Rodikova, Ekaterina ^a   Weese Mayer, Debra E ^b   Rand, Casey M ^b   Marazita, Mary L ^c   Cooper, Margaret E ^c   Berry Kravis, Elizabeth M ^d   Bech Hansen, N Torben ^a   Wilson, Richard J A ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Genetic variant; PAC1 receptor; Pituitary adenylate cyclase activating polypeptide; Sudden infant death syndrome

Indexed keywords

5' UNTRANSLATED REGION; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DNA SEQUENCE; ETHNICITY; EXON; FEMALE; GENE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INFANT; INTRON; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PAC1 RECEPTOR GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SUDDEN INFANT DEATH SYNDROME; CASE CONTROL STUDY; CLINICAL TRIAL; EPIDEMIOLOGY; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; MULTICENTER STUDY; UNITED STATES;

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR 1;

AFRICAN AMERICANS; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; MALE; MARYLAND; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, TYPE I; SUDDEN INFANT DEATH;

EID: 84887437742     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/apa.12405     Document Type: Article

References (29)

1. Willinger M, James LS, Catz C,. Defining the sudden infant death syndrome (SIDS): deliberations of an expert panel convened by the National Institute of Child Health and Human Development. Pediatr Pathol 1991; 11: 677-84.
2. Matthews TJ, MacDorman MF,. Infant mortality statistics from the 2007 period linked birth/infant death data set. Natl Vital Stat Rep 2011; 59: 1-31.
3. Hauck FR, Tanabe KO,. International trends in sudden infant death syndrome: stabilization of rates requires further action. Pediatrics 2008; 122: 660-6.
4. Gilbert NL, Fell DB, Joseph KS, Liu S, Leon JA, Sauve R, et al. Temporal trends in sudden infant death syndrome in Canada from 1991 to 2005: contribution of changes in cause of death assignment practices and in maternal and infant characteristics. Paediatr Perinat Epidemiol 2012; 26: 124-30.
5. Blakely T, Ajwani S, Robson B, Tobias M, Bonne M,. Decades of disparity: widening ethnic mortality gaps from 1980 to 1999. N Z Med J 2004; 117: U995.
6. Freemantle CJ, Read AW, de Klerk NH, McAullay D, Anderson IP, Stanley FJ,. Sudden infant death syndrome and unascertainable deaths: trends and disparities among Aboriginal and non-Aboriginal infants born in Western Australia from 1980 to 2001. J Paediatr Child Health 2006; 42: 445-51. (Pubitemid 44114658)
7. Molteno CD, Ress E, Kibel MA,. Early childhood mortality in Cape Town. S Afr Med J 1989; 75: 570-4. (Pubitemid 19190527)
8. Hauck FR, Tanabe KO, Moon RY,. Racial and ethnic disparities in infant mortality. Semin Perinatol 2011; 35: 209-20.
9. Van Norstrand DW, Ackerman MJ,. Genomic risk factors in sudden infant death syndrome. Genome Med 2010; 2: 86-95.
10. Cummings KJ, Klotz C, Liu W-Q, Weese-Mayer DE, Marazita ML, Cooper ME, et al. Sudden infant death syndrome (SIDS) in African Americans: polymorphisms in the gene encoding the stress peptide pituitary adenylate cyclase-activating polypeptide (PACAP). Acta Paediatr 2009; 98: 482-9.
11. Sherwood NM, Krueckl SL, McRory JE,. The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr Rev 2000; 21: 619-70. (Pubitemid 32113287)
12. Miyata A, Jiang L, Dahl RD, Kitada C, Kubo K, Fujino M, et al. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun 1990; 170: 643-8. (Pubitemid 20249468)
13. Hannibal J,. Pituitary adenylate cyclase-activating peptide in the rat central nervous system: an immunohistochemical and in situ hybridization study. J Comp Neurol 2002; 453: 389-417. (Pubitemid 35231190)
14. Hashimoto H, Shintani N, Baba A,. New insights into the central PACAPergic system from the phenotypes in PACAP- and PACAP receptor-knockout mice. Ann N Y Acad Sci 2006; 1070: 75-89. (Pubitemid 44126626)
15. Harmar AJ, Arimura A, Gozes I, Journot L, Laburthe M, Pisegna JR, et al. International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev 1998; 50: 265-70. (Pubitemid 28304027)
16. Hashimoto H, Shintani N, Tanaka K, Mori W, Hirose M, Matsuda T, et al. Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP). Proc Natl Acad Sci USA 2001; 98: 13355-60. (Pubitemid 33051367)
17. Gray SL, Cummings KJ, Jirik FR, Sherwood NM,. Targeted disruption of the pituitary adenylate cyclase-activating polypeptide gene results in early postnatal death associated with dysfunction of lipid and carbohydrate metabolism. Mol Endocrinol 2001; 15: 1739-47. (Pubitemid 32939304)
18. Jamen F, Persson K, Bertrand G, Rodriguez-Henche N, Puech R, Bockaert J, et al. PAC1 receptor-deficient mice display impaired insulinotropic response to glucose and reduced glucose tolerance. J Clin Invest 2000; 105: 1307-15. (Pubitemid 30266084)
19. Otto C, Kovalchuk Y, Wolfer DP, Gass P, Martin M, Zuschratter W, et al. Impairment of mossy fiber long-term potentiation and associative learning in pituitary adenylate cyclase activating polypeptide type 1 receptor-deficient mice. J Neurosci 2001; 21: 5520-7. (Pubitemid 32692150)
20. Wilson RJA, Cummings KJ,. Pituitary adenylate cyclase-activating polypeptide is vital for neonatal survival and the neuronal control of breathing. Respir Physiol Neurobiol 2008; 164: 168-78.
21. Weese-Mayer DE, Berry-Kravis EM, Maher BS, Silvestri JM, Curran ME, Marazita ML,. Sudden infant death syndrome: association with a promoter polymorphism of the serotonin transporter gene. Am J Med Genet A 2003; 117A: 268-74. (Pubitemid 37063992)
22. Rozen S, Skaletsky H,. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000; 132: 365-86.
23. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-75. (Pubitemid 47330214)
24. Zhao JH, Lissarrague S, Essioux L, Sham PC,. GENECOUNTING: haplotype analysis with missing genotypes. Bioinformatics 2002; 18: 1694-5. (Pubitemid 36097739)
25. Stenson PD, Mort M, Ball EV, Howells K, Phillips AD, Thomas NS, et al. The human gene mutation database: 2008 update. Genome Med 2009; 1: 13-8.
26. Weese-Mayer DE, Zhou L, Berry-Kravis EM, Maher BS, Silvestri JM, Marazita ML,. Association of the serotonin transporter gene with sudden infant death syndrome: a haplotype analysis. Am J Med Genet A 2003; 122A: 238-45. (Pubitemid 37152870)
27. Weese-Mayer DE, Berry-Kravis EM, Zhou L, Maher BS, Curran ME, Silvestri JM, et al. Sudden infant death syndrome: case-control frequency differences at genes pertinent to early autonomic nervous system embryologic development. Pediatr Res 2004; 56: 391-5. (Pubitemid 39128824)
28. Rand CM, Berry-Kravis EM, Zhou L, Fan W, Weese-Mayer DE,. Sudden infant death syndrome: rare mutation in the serotonin system fev gene. Pediatr Res 2007; 62: 180-2. (Pubitemid 47205718)
29. Plant LD, Bowers PN, Liu Q, Morgan T, Zhang T, State MW, et al. A common cardiac sodium channel variant associated with sudden infant death in African Americans, SCN5A S1103Y. J Clin Invest 2006; 116: 430-5. (Pubitemid 43228360)